Cargando…
Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Severe COVID-19
During the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), many critically ill patients died of severe pneumonia, acute respiratory distress syndrome (ARDS), or multiple organ dysfunction syndrome. To date, no specific treatments have been proven to be effective for coronav...
Autores principales: | Xiong, Jing, Chen, Long, Zhang, Li, Bao, Lei, Shi, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930651/ https://www.ncbi.nlm.nih.gov/pubmed/33650894 http://dx.doi.org/10.1177/0963689721995455 |
Ejemplares similares
-
Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy: Promise and Challenges
por: Wang, Shihua H., et al.
Publicado: (2021) -
Mesenchymal stromal cells: promising treatment for liver cirrhosis
por: Yao, Lichao, et al.
Publicado: (2022) -
Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?
por: Hamdan, Hamdan, et al.
Publicado: (2021) -
Convalescent plasma as a potential therapy for COVID-19
por: Chen, Long, et al.
Publicado: (2020) -
Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming
por: Sanchez-Castro, E. Eduardo, et al.
Publicado: (2021)